Advanced Biomed Inc.
ADVB
$1.86
-$0.04-2.11%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -3.04M | -2.28M | -2.78M | -3.53M | -- |
| Total Depreciation and Amortization | 306.90K | 281.20K | 268.30K | 246.10K | -- |
| Total Amortization of Deferred Charges | 131.40K | 131.40K | 131.40K | 202.10K | -- |
| Total Other Non-Cash Items | 0.00 | 0.00 | 0.00 | 150.20K | -- |
| Change in Net Operating Assets | 187.90K | 327.20K | 256.40K | 1.75M | -- |
| Cash from Operations | -2.41M | -1.54M | -2.13M | -1.18M | -- |
| Capital Expenditure | -35.90K | -94.20K | -74.20K | -271.80K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -50.50K | -- |
| Other Investing Activities | -- | -- | -- | 60.70K | -- |
| Cash from Investing | -35.90K | -94.20K | -74.20K | -261.50K | -- |
| Total Debt Issued | 1.48M | 1.75M | 1.66M | 1.34M | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | 11.60K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 209.60K | 192.80K | 209.60K | -465.50K | -- |
| Cash from Financing | 1.69M | 1.95M | 1.87M | 882.10K | -- |
| Foreign Exchange rate Adjustments | 642.90K | -255.40K | 319.30K | 723.70K | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -119.40K | 59.80K | -14.30K | 162.80K | -- |